Lertsuwan, J., Sawasdichai, A., Tasnawijitwong, N., Gaston, K., Jayaraman, P. S., & Satayavivad, J. (2021). Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro. Anticancer Res, 41(12), 6155-6167. doi:10.21873/anticanres.15435

Schaffer, A. A., Dominguez, D. A., Chapman, L. M., Gertz, E. M., Budhu, A., Forgues, M., . . . Wang, X. W. (2021). Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis. BMC Genomics, 22(1), 814. doi:10.1186/s12864-021-08098-9

Pomyen, Y., Budhu, A., Chaisaingmongkol, J., Forgues, M., Dang, H., Ruchirawat, M., . . . Consortium, T.-L. (2021). Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma. Sci Rep, 11(1), 12097. doi:10.1038/s41598-021-91560-1

Hung, M. H., Lee, J. S., Ma, C., Diggs, L. P., Heinrich, S., Chang, C. W., . . . Wang, X. W. (2021). Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat Commun, 12(1), 1455. doi:10.1038/s41467-021-21804-1

Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050